Full history for every metric is available with a Kvantra account
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INR bn | 10.6 | 25.1 | 39.4 | 45.6 | 54.1 | 70.3 | 83.7 | 87.1 |
| Operating profit | INR bn | 18.0 | 18.4 | ||||||
| Net profit | INR bn | 0.6 | -1.4 | 6.1 | 11.0 | 10.6 | 10.8 | 14.4 | 14.6 |
| EPS reported | INR | 14.75 | 14.91 | ||||||
| Operating cashflow per share | INR | 16.80 | 8.40 | ||||||
| Capex per share | INR | 15.27 | 8.83 | ||||||
| FCF per share | INR | 1.53 | -0.42 | ||||||
| Free cash flow | INR bn | 1.49 | -0.41 | ||||||
| Net debt | INR bn | 21.4 | -6.7 | ||||||
| Book value equity | INR bn | 107 | 107 | ||||||
| Book value per share | INR | 109.9 | 110.0 | ||||||
| Number of shares | m | 977.77 | 977.24 | ||||||
| DPS (TTM paid) | INR | 2.00 | 2.00 |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 65.20 | 54.80 | ||||||
| P/B LTM | x | 8.67 | 7.38 | ||||||
| P/S LTM | x | 11.13 | 9.11 | ||||||
| P/FCF LTM | x | 626.56 | -1,920.23 | ||||||
| EV/EBITDA LTM | x | 40.74 | 32.83 | ||||||
| EV/Sales LTM | x | 11.47 | 9.03 | ||||||
| Earnings Yield LTM | % | 1.53% | 1.82% | ||||||
| FCF Yield | % | 0.16% | -0.05% | ||||||
| Quality | |||||||||
| ROE | % | 13.42% | 14.01% | ||||||
| ROIC | % | 9.95% | 0.00% | ||||||
| Operating margin | % | 21.45% | 21.17% | ||||||
| Gross margin | % | 78.62% | 56.44% | ||||||
| FCF/Sales | % | 1.78% | -0.47% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +33.97% | +27.11% | ||||||
| Sales Growth YoY | % | +19.14% | +15.96% | ||||||
| Net Income Growth YoY | % | +34.07% | +26.96% | ||||||
| FCF Growth | % | -69.87% | - | ||||||
| Operating Profit Growth | % | -38.10% | -40.53% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.16% | 0.24% | ||||||
| Dividend Growth | % | +33.33% | +33.33% | ||||||
| Payout Ratio | % | 10.10% | 10.00% | ||||||
| FCF/Debt | x | 0.04 | - | ||||||
| Net Debt/EBITDA | x | 1.19 | 0.00 | ||||||
| EBIT/Net interest | x | 7.64 | 7.34 | ||||||
| Net debt/market cap | % | 2.29% | -0.84% | ||||||
| Net debt/Equity | x | 0.20 | -0.06 | ||||||
| Gross debt/equity | x | 0.32 | 0.00 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Max Healthcare Institute Ltd (MAXHEALTH.BO)
Based on consensus from external analysts. Not Kvantra's opinion.
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free